MTOR and familial hypercholesterolemia: This result may be related to the fact that the recipients on mTOR inhibition were those with an advanced hepatoceulluar carcinoma, suggesting that hypercholesterolemia may be associated with graft failure only in an advanced hepatoceulluar carcinoma, but it may not affect the association between hypercholesterolemia and MACE.